|
Immunotherapy
Citations 281-290 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell–depleted allografts
- Peter Lang, Karin Barbin, Tobias Feuchtinger, Johann Greil, Matthias Peipp, Susan J. Zunino, Matthias Pfeiffer, Rupert Handgretinger, Dietrich Niethammer, and Georg H. Fey
Blood 2004; 103: 3982-3985.
[Abstract]
[Full text]
[PDF]
Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions
- Gerard Lozanski, Nyla A. Heerema, Ian W. Flinn, Lisa Smith, Jennifer Harbison, Jennifer Webb, Mollie Moran, Margaret Lucas, Thomas Lin, Marcy L. Hackbarth, John H. Proffitt, David Lucas, Michael R. Grever, and John C. Byrd
Blood 2004; 103: 3278-3281.
[Abstract]
[Full text]
[PDF]
Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection
- Claire E. Farel, Doreen G. Chaitt, Barbara K. Hahn, Jorge A. Tavel, Joseph A. Kovacs, Michael A. Polis, Henry Masur, Dean A. Follmann, H. Clifford Lane, and Richard T. Davey, Jr
Blood 2004; 103: 3282-3286.
[Abstract]
[Full text]
[PDF]
Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants
- Georg Rauser, Hermann Einsele, Christian Sinzger, Dorothee Wernet, Gabriele Kuntz, Mario Assenmacher, John D. M. Campbell, and Max S. Topp
Blood 2004; 103: 3565-3572.
[Abstract]
[Full text]
[PDF]
A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas
- Gunilla Enblad, Hans Hagberg, Martin Erlanson, Jeanette Lundin, Anja Porwit MacDonald, Roland Repp, Johannes Schetelig, Gernot Seipelt, and Anders Österborg
Blood 2004; 103: 2920-2924.
[Abstract]
[Full text]
[PDF]
Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients
- Sigbjørn Berentsen, Elling Ulvestad, Bjørn Tore Gjertsen, Henrik Hjorth-Hansen, Ruth Langholm, Håvar Knutsen, Waleed Ghanima, Fuad Victor Shammas, and Geir E. Tjønnfjord
Blood 2004; 103: 2925-2928.
[Abstract]
[Full text]
[PDF]
Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help
- Hendrik Poeck, Moritz Wagner, Julia Battiany, Simon Rothenfusser, Daniela Wellisch, Veit Hornung, Bernd Jahrsdorfer, Thomas Giese, Stefan Endres, and Gunther Hartmann
Blood 2004; 103: 3058-3064.
[Abstract]
[Full text]
[PDF]
Unexpectedly, induction of cytotoxic T lymphocytes enhances the humoral response after DNA immunization
- Christopher M. Dyer, Yifan Zhan, Jamie L. Brady, Francis R. Carbone, Mark J. Smyth, and Andrew M. Lew
Blood 2004; 103: 3073-3075.
[Abstract]
[Full text]
[PDF]
Identification and in vitro expansion of CD4+ and CD8+ T cells specific for human neutrophil elastase
- Hiroshi Fujiwara, Frank El Ouriaghli, Matthias Grube, David A. Price, Katayoun Rezvani, Emma Gostick, Giuseppe Sconocchia, Jos Melenhorst, Nancy Hensel, Daniel C. Douek, and A. John Barrett
Blood 2004; 103: 3076-3083.
[Abstract]
[Full text]
[PDF]
Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?
- Christian Demanet, Arend Mulder, Veronique Deneys, Maria J. Worsham, Piet Maes, Frans H. Claas, and Soldano Ferrone
Blood 2004; 103: 3122-3130.
[Abstract]
[Full text]
[PDF]
|
|
